Protein Antigen Adsorption to the DDA/TDB Liposomal Adjuvant: Effect on Protein Structure, Stability, and Liposome Physicochemical Characteristics

Pharmaceutical Research

Volumn 30, Issue 1, 2013, Pages 140-155

  Hamborg, Mette ^a   Jorgensen, Lene ^a   Bojsen, Anders Riber ^a   Christensen, Dennis ^b   Foged, Camilla ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

adjuvant; dimethyldioctadecylammonium; liposome; protein structure; vaccine delivery

Indexed keywords

BOVINE SERUM ALBUMIN; DIMETHYLDIOCTADECYLAMMONIUM; GLYCOLIPID; IMMUNOLOGICAL ADJUVANT; LIPOSOME; LYSOZYME; OVALBUMIN; QUATERNARY AMMONIUM DERIVATIVE; TREHALOSE 6,6' DIBEHENATE; TREHALOSE 6,6'-DIBEHENATE;

ADSORPTION; ANIMAL; ARTICLE; CATTLE; CHEMISTRY; COLLOID; PHASE TRANSITION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ANIMALS; CATTLE; COLLOIDS; GLYCOLIPIDS; LIPOSOMES; MURAMIDASE; OVALBUMIN; PHASE TRANSITION; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; QUATERNARY AMMONIUM COMPOUNDS; SERUM ALBUMIN, BOVINE;

EID: 85027942412     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0856-8     Document Type: Article

References (45)

1. Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol. 2011;11:865–72.
2. Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci. 2009;98(4):1278–316.
3. Volkin DB, Middaugh CR. Vaccines as physically and chemically well-defined pharmaceutical dosage forms. Expert Rev Vaccines. 2010;9(7):689–91.
4. Jones LS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem. 2005;280(14):13406–14.
5. Dong A, Jones LS, Kerwin BA, Krishnan S, Carpenter JF. Secondary structures of proteins adsorbed onto aluminum hydroxide: infrared spectroscopic analysis of proteins from low solution concentrations. Anal Biochem. 2006;351(2):282–9.
6. Carra JH, Wannemacher RW, Tammariello RE, Lindsey CY, Dinterman RE, Schokman RD, et al. Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity. Vaccine. 2007;25(21):4149–58.
7. Bai SF, Dong AC. Effects of immobilization onto aluminum hydroxide particles on the thermally induced conformational behavior of three model proteins. Int J Biol Macromol. 2009;45(1):80–5.
8. Ausar SF, Chan JD, Hoque W, James O, Jayasundara K, Harper K. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuyanted vaccines. J Pharm Sci. 2011;100(2):431–40.
9. Soliakov A, Kelly IF, Lakey JH, Watkinson A. Anthrax sub-unit vaccine: the structural consequences of binding rPA83 to alhydrogel. Eur J Pharm Biopharm. 2012;80(1):25–32.
10. Miles AP, McClellan HA, Rausch KM, Zhu D, Whitmore MD, Singh S, et al. Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations. Vaccine. 2005;23(19):2530–9.
11. Jorgensen L, Wood GK, Rosenkrands I, Petersen C, Christensen D. Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF). J Liposome Res. 2009;19(2):99–104.
12. Silva VD, Takata CS, Sant’Anna OA, Lopes AC, De Araujo PS, Da Costa MHB. Enhanced liposomal vaccine formulation and performance: Simple physicochemical and immunological approaches. J Liposome Res. 2006;16(3):215–27.
13. Xue XY, Ding F, Zhang QF, Pan XG, Qu L, Pan WQ. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1 (III) chimeric vaccine candidate with Montanide ISA720 adjuvant. Vaccine. 2010;28(18):3152–8.
14. Nordly P, Madsen HB, Nielsen HM, Foged C. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opin Drug Deliv. 2009;6(7):657–72.
15. Hem SL, Hogenesch H, Middaugh CR, Volkin DB. Preformulation studies-The next advance in aluminum adjuvant-containing vaccines. Vaccine. 2010;28(31):4868–70.
16. Jorgensen L, Vermehren C, Bjerregaard S, Froekjaer S. Secondary structure alterations in insulin and growth hormone water-in-oil emulsions. Int J Pharm. 2003;254(1):7–10.
17. Henriksen-Lacey M, Christensen D, Bramwell VW, Lindenstrom T, Agger EM, Andersen P, et al. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release. 2010;145(2):102–8.
18. Kamath AT, Mastelic B, Christensen D, Rochat AF, Agger EM, Pinschewer DD, et al. Synchronization of Dendritic Cell Activation and Antigen Exposure Is Required for the Induction of Th1/Th17 Responses. J Immunol. 2012;188(10):4828–37.
19. Davidsen J, Rosenkrands I, Christensen D, Vangala A, Kirby D, Perrie Y, et al. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses. Biochim Biophys Acta. 2005;1718(1–2):22–31.
20. Kendrick BS, Dong AC, Allison SD, Manning MC, Carpenter JF. Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states. J Pharm Sci. 1996;85(2):155–8.
21. Henriksen-Lacey M, Bramwell VW, Christensen D, Agger EM, Andersen P, Perrie Y. Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. J Control Release. 2009;142(2):180–6.
22. Christensen D, Kirby D, Foged C, Agger EM, Andersen P, Perrie Y, et al. alpha, alpha′-trehalose 6,6′-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochim Biophys Acta. 2008;1778(5):1365–73.
23. Jeyachandran YL, Mielezarski E, Rai B, Mielczarski JA. Quantitative and qualitative evaluation of adsorption/desorption of bovine serum albumin on hydrophilic and hydrophobic surfaces. Langmuir. 2009;25(19):11614–20.
24. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2006;104(7):2050–5.
25. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci. 2007;134–135:167–74.
26. Muga A, Mantsch HH, Surewicz WK. Apocytochrome-C interaction with phospholipid-membranes studied by fourier-transform infrared-spectroscopy. Biochemistry. 1991;30(10):2629–35.
27. Persson D, Thoren PEG, Norden B. Penetratin-induced aggregation and subsequent dissociation of negatively charge phospholipid vesicles. FEBS Lett. 2001;505(2):307–12.
28. Papahadjopoulos D, Moscarello M, Eylar EH, Isac T. Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim Biophys Acta. 1975;401(3):317–35.
29. Haskard CA, Li-Chan ECY. Hydrophobicity of bovine serum albumin and ovalbumin determined using uncharged (PRODAN) and anionic (ANS(−)) fluorescent probes. J Agric Food Chem. 1998;46(7):2671–7.
30. Bruylants G, Wouters J, Michaux C. Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem. 2005;12(17):2011–20.
31. Robertson AD, Murphy KP. Protein structure and the energetics of protein stability. Chem Rev. 1997;97(5):1251–67.
32. Charbonneau DM, Tajmir-Riahi HA. Study on the interaction of cationic lipids with bovine serum albumin. J Phys Chem B. 2010;114(2):1148–55.
33. Norde W, Favier JP. Structure of adsorbed and desorbed proteins. Colloid Surface. 1992;64(1):87–93.
34. Wallace BA. Protein characterisation by synchrotron radiation circular dichroism spectroscopy. Q Rev Biophys. 2009;42(4):317–70.
35. Wallace BA, Teeters CL. Differential absorption flattening optical effects are significant in the circular dichroism spectra of large membrane fragments. Biochemistry. 1986;26(1):65–70.
36. Wallace BA, Mao D. Circular dichroism analyses of membrane proteins: an examination of differential light scattering and absorption flattening effects in large membrane vesicles and membrane sheets. Anal Biochem. 1984;142(2):317–28.
37. Ladokhin AS. FAU - Fernandez-Vidal M, Fernandez-Vidal MF, White SH. CD spectroscopy of peptides and proteins bound to large unilamellar vesicles. J Membr Biol. 2010;236:247–53.
38. Jackson M, Mantsch HH. The use and misuse of ftir spectroscopy in the determination of protein-structure. Crit Rev Biochem Mol Biol. 1995;30(2):95–120.
39. Cawthern KM, Permyakov E, Berliner LJ. Membrane-bound states of alpha-lactalbumin: implications for protein stability and conformation. Protein Sci. 1996;5(7):1394–405.
40. Grudzielanek S, Smirnovas V, Winter R. The effects of various membrane physical-chemical properties on the aggregation kinetics of insulin. Chem Phys Lipids. 2007;149(1–2):28–39.
41. Ingvarsson PT, Yang MS, Nielsen HM, Rantanen J, Foged C. Stabilization of liposomes during drying. Expert Opin Drug Deliv. 2011;8(3):375–88.
42. Peters T. Serum-Albumin. Adv Protein Chem. 1985;37:161–245.
43. Blake CCF, Koenig DF, Mair GA, North ACT, Phillips DC, Sarma VR. Structure of hen egg-white lysozyme - a 3-dimensional fourier synthesis at 2A resolution. Nature. 1965;206(4986):757–61.
44. Stein PE, Leslie AGW, Finch JT, Carrell RW. Crystal-structure of uncleaved ovalbumin at 1.95 A resolution. J Mol Biol. 1991;221(3):941–59.
45. Stevens L. Egg-white proteins. Comp Biochem Physiol B Biochem Mol Biol. 1991;100(1):1–9.